Predicted protein targets (top 2)
Click a target to see other patent compounds predicted against it — the reverse direction, in place.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL6176578 | 0.88 | CCKBR (0.43) | CCKBRNPY1R | |
| SCHEMBL6176498 | 0.85 | CCKBR (0.44) | CCKBR | |
| SCHEMBL6176549 | 0.84 | CCKBR (0.37) | CCKBR | |
| SCHEMBL6179236 | 0.81 | CCKBR (0.54) | CCKBRNPY1R | |
| SCHEMBL6178421 | 0.80 | CCKBR (0.51) | CCKBRNPY1R | |
| SCHEMBL8310266 | 0.80 | CCKBR (0.42) | CCKBRNPY1R | |
| SCHEMBL6181360 | 0.79 | CCKBR (0.56) | CCKBRNPY1R | |
| SCHEMBL6181356 | 0.78 | CCKBR (0.56) | CCKBRNPY1R | |
| SCHEMBL6176525 | 0.76 | CCKBR (0.59) | CCKBRNPY1R | |
| SCHEMBL6178982 | 0.75 | ACE (0.41) | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-0945445-B9 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2005-12-28 | — | — | EP | disclosed |
| EP-0945445-B1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARM CO LTD (JP) | 2003-09-03 | — | — | EP | disclosed |
| US-6239131-B1 | WHICH HAVE GASTRIN AND/OR CCK-B (CHOLECYSTOKININ-B) RECEPTOR ANTAGONISM, USEFUL AS REMEDIES FOR GASTRIC ULCER AND GASTROINTESTINAL MOVEMENT DISORDER. | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 2001-05-29 | — | — | US | disclosed |
| EP-0945445-A1 | 1,5-BENZODIAZEPINE DERIVATIVES | ZERIA PHARMACEUTICAL CO., LTD. (JP) | 1999-09-29 | — | — | EP | disclosed |